Suchergebnisse - "van de Borne, Philippe"

PubPharm (7)

1

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

enthalten in: European heart journal | 2018

von Fitchett, D. | Butler, J. | van de Borne, P. | +9

CommentIn: Eur Heart J. 2018 Feb 1;39(5):371-373. - PMID 29020326

2

Rivaroxaban with or without aspirin in patients with stable coronary artery disease : an international, randomised, double-blind, placebo-controlled trial

enthalten in: Lancet (London, England) | 2018

von Connolly, S. | Eikelboom, J. | Bosch, J. | +128

CommentIn: Lancet. 2018 Jan 20;391(10117):181-182. - PMID 29132878

3

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease : an international, randomised, double-blind, placebo-controlled trial

enthalten in: Lancet (London, England) | 2018

von Anand, S. | Bosch, J. | Eikelboom, J. | +130

CommentIn: Lancet. 2018 Jan 20;391(10117):183-184. - PMID 29132877

4

Pre-hospital management of acute coronary syndrome patients in Belgium and Luxembourg and other Western European countries

enthalten in: Acta cardiologica | 2016

von Beauloye, C. | Vrolix, M. | Claeys, M. | +3

5

Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes : a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The lancet. Diabetes & endocrinology | 2013

von Roden, M. | Weng, J. | Eilbracht, J. | +105

CommentIn: Lancet Diabetes Endocrinol. 2013 Nov;1(3):168-70. - PMID 24622357

6

Belgian global implementation of cardiovascular and stroke risk assessment study : methods and baseline data of the BELGICA-STROKE STUDY

enthalten in: European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology | 2011

von Van der Niepen, P. | Thijs, V. | Devroey, D. | +3

7

Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. the QoLaN study

enthalten in: Blood pressure. Supplement | 2009

von Hermans, M. | De Coster, O. | Seidel, L. | +2

CommentIn: Blood Press Suppl. 2009 Oct;1:3-4. - PMID 20050099

1
[1]